JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon (NYSE: OGN), a global healthcare company with a mission to improve the health of women throughout their lives, and Dermavant Sciences Ltd. announced today ...
Vtama (tapinarof) is a brand-name drug that’s prescribed for plaque psoriasis in adults. Vtama comes as a topical cream that’s typically applied to affected areas of skin once per day. Vtama belongs ...
Vtama is a nonsteroidal cream for plaque psoriasis. Plaque psoriasis is a condition where the immune system causes the skin to make too many new cells too quickly. These extra skin cells pile up on ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. 82.8% of patients treated with Vtama achieved the ...
In May of last year, when Dermavant gained its first approval for Vtama (tapinarof), the company’s CEO Todd Zavodnick proclaimed that the topical cream was on its way to changing the standard of care ...
More patients treated with Vtama achieved vIGA-AD success compared with those who received vehicle cream in both ADORING 1 (45% vs 14%) and ADORING 2 (46% vs 18%). The Food and Drug Administration ...
Incyte’s Opzelura cream may be looking at a new competitive rival in the lucrative atopic dermatitis field. Wednesday, Dermavant Sciences said its topical drug Vtama has come out successful in the ...
Please provide your email address to receive an email when new articles are posted on . 45.4% of children and adults receiving Vtama improved to clear or almost clear in validated IGA for atopic ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Dermavant Sciences' Vtama cream met the main goal of achieving clearer skin in a second phase 3 trial to treat adults and pediatric patients down to 2 years old with moderate to severe atopic ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results